Medical Use Tampons

The Mademoicell Stem Cell Collector by Chelsea Briganti

The Mademoicell stem cell collector will surely revolutionize the way women view their menstrual cycle, but also how we view what is still considered experimental medicine. Considering that "stem cell medicine is quickly approaching clinical use," according to Fast Company, awareness of this option at home may help grow the movement.

Conceived by Parsons student Chelsea Briganti, the Mademoicell stem cell collector is essentially a tampon that collects menstrual blood. Although it is definitely a squeamish concept, I can only focus on the benefits of this simple device -- especially when you take into account how acceptable menstrual blood is over other stem cell alternatives.

Home Stem Cell Collection
The Mademoicell stem cell collector creates a new market for in-home stem cell collection and opens opportunities for advancements in stem cell therapies.
Revolutionizing Menstruation
By changing the way women view their menstrual cycle, the Mademoicell also creates opportunities for new menstrual health products and services.
Democratizing Medicine
The Mademoicell makes stem cell collection accessible to more people, creating opportunities for more diverse and affordable medical treatments.

Sectors Adopting This

Women's Health
The Mademoicell and related products have the potential to disrupt the women's health industry by offering innovative solutions for menstrual care and stem cell collection.
Stem Cell Research and Therapies
The Mademoicell could revolutionize the stem cell industry by providing a new, non-invasive method for collecting stem cells, potentially opening the door for new therapies and treatments.
Medical Technology
The technology behind the Mademoicell could also have applications beyond stem cell collection, creating opportunities for innovation in medical technology and devices.
SCORE
4.4 out of 10
GENDER
10% Men90% Women
MARKETTop markets: North America, South America, Europe, Asia, Africa
GENERATION
  • Gen Alpha
  • Gen Z (primary audience)
  • Millennial (primary audience)
  • Gen X (primary audience)
POPULARITY
Popularity 48%
Activity 76%
Freshness 8%